Skip to main content

Table 5 Evaluation of events (cough) between the two groups is expressed as Relative Risk and Relative Risk reduction (RR, RRR), 95% confidence intervals (CI) and p-values. A p-value smaller than 0.05 was considered statistically significant

From: Efficacy and safety of the syrup “KalobaTUSS®” as a treatment for cough in children: a randomized, double blind, placebo-controlled clinical trial

  KalobaTUSS® (children with cough) Placebo (children with cough) RR (95% CI) RRR (95% CI) p
Night time cough after 4 days of treatment 34/54 43/52 0.76 (0.6–0.9) 0.24 (0.032–0.40) 0.0256
Night time cough after 8 days of treatment 7/54 22/52 0.306 (0.143–0.65) 0.69 (0.34–0.85) 0.0023
Day time cough after 4 days of treatment 38/54 45/52 0.81 (0.66–0.99) 0.18 (0.0032–0.33) 0.046
Day time cough after 8 days of treatment 8/54 24/52 0.32 (0.16–0.65) 0.68 (0.35–0.84) 0.0016